PEOPLE - Changes at 3i:
This article was originally published in Clinica
3i UK venture capital team leader Jo Taylor will succeed Rod Perry (retiring) as overall head of the London, UK group's global venture capital business on January 1. The group's VC business invested £74m ($143m) in early stage tech companies (healthcare, software, communications, electronics) in the first half of 2004.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.